Effects of Tetrahydrobiopterin on Blood Pressure

Trial Profile

Effects of Tetrahydrobiopterin on Blood Pressure

Completed
Phase of Trial: Phase 0

Latest Information Update: 15 Nov 2013

At a glance

  • Drugs Sapropterin (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2012 Additional lead trial centre (American Heart Association) identified as reported by ClinicalTrials.gov record.
    • 09 Jul 2012 Actual initiation date (December 2004) added as reported by ClinicalTrials.gov record.
    • 15 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top